Stock GWPH GW PHARMACEUTICALS PLC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Analyst Reco. GW Pharmaceuticals plc

Equities

GWPH

US36197T1034

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Fitch Affirms Jazz's IDR at 'BB-'; Outlook Positive
AQ
GW PHARMACEUTICALS : SVB Leerink Downgrades GW Pharmaceuticals to Market Perform From Outperform, Adjusts Price Target to $220 from $200
MT
GW PHARMACEUTICALS : Morgan Stanley Downgrades GW Pharmaceuticals to Equal-Weight From Overweight, Adjusts Price Target to $220 From $193
MT
GW PHARMACEUTICALS : HC Wainwright Downgrades GW Pharmaceuticals to Neutral From Buy, Adjusts Price Target to $220 From $162
MT
GW PHARMACEUTICALS : Needham Downgrades GW Pharmaceuticals to Hold from Buy
MT
GW PHARMACEUTICALS : Cantor Fitzgerald Adjusts Price Target on GW Pharmaceuticals to $147 From $165, Maintains Overweight Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GWPH Stock
  4. News GW Pharmaceuticals plc
  5. Analyst Reco.